Aura Biosciences annual capital expenditures (capex)
2020
2021
2022
2023
2024
2025
Aura Biosciences Capital Expenditures (CapEx) Growth & History (AURA)
Aura Biosciences's capital expenditures (capex) was $447,000 for fiscal 2025.
View full Aura Biosciences company overviewAura Biosciences annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $447,000 | −$806,000 | −64.33% |
| 2024 | 2024-12-31 | $1.3M | $544,000 | +76.73% |
| 2023 | 2023-12-31 | $709,000 | −$385,000 | −35.19% |
| 2022 | 2022-12-31 | $1.1M | −$1.0M | −48.52% |
| 2021 | 2021-12-31 | $2.1M | $1.4M | +175.62% |
| 2020 | 2020-12-31 | $771,000 | — | — |
Aura Biosciences quarterly capital expenditures (capex)
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $21,000 | −$18,000 | −46.15% |
| Q1 2026 | 2026-03-31 | $102,000 | −$85,000 | −45.45% |
| Q4 2025 | 2025-12-31 | $176,000 | −$123,000 | −41.14% |
| Q3 2025 | 2025-09-30 | $45,000 | −$296,000 | −86.80% |
| Q2 2025 | 2025-06-30 | $39,000 | −$486,000 | −92.57% |
| Q1 2025 | 2025-03-31 | $187,000 | $99,000 | +112.50% |
| Q4 2024 | 2024-12-31 | $299,000 | −$18,000 | −5.68% |
| Q3 2024 | 2024-09-30 | $341,000 | $251,000 | +278.89% |
| Q2 2024 | 2024-06-30 | $525,000 | $332,000 | +172.02% |
| Q1 2024 | 2024-03-31 | $88,000 | −$21,000 | −19.27% |
| Q4 2023 | 2023-12-31 | $317,000 | −$41,000 | −11.45% |
| Q3 2023 | 2023-09-30 | $90,000 | $27,000 | +42.86% |
| Q2 2023 | 2023-06-30 | $193,000 | $119,000 | +160.81% |
| Q1 2023 | 2023-03-31 | $109,000 | −$490,000 | −81.80% |
| Q4 2022 | 2022-12-31 | $358,000 | −$461,000 | −56.29% |
| Q3 2022 | 2022-09-30 | $63,000 | −$510,000 | −89.01% |
| Q2 2022 | 2022-06-30 | $74,000 | −$588,000 | −88.82% |
| Q1 2022 | 2022-03-31 | $599,000 | $528,000 | +743.66% |
| Q4 2021 | 2021-12-31 | $819,000 | — | — |
| Q3 2021 | 2021-09-30 | $573,000 | — | — |
| Q2 2021 | 2021-06-30 | $662,000 | — | — |
| Q1 2021 | 2021-03-31 | $71,000 | — | — |
Aura Biosciences capital expenditures (capex) trends
Over the last five fiscal years, Aura Biosciences's capital expenditures (capex) decreased from $771,000 to $447,000, a change of −$324,000. The latest reported quarter, Q2 2026, shows $21,000.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Aura Biosciences source filings ↗